Filing Details
- Accession Number:
- 0000950170-24-131628
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 17:35:03
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-27 17:35:03
- Original Submission Date:
- 2024-11-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1468328 | Addus Homecare Corp | ADUS | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253500 | Dirk R Allison | 6303 Cowboys Way Suite 600 Frisco TX 75034 | Ceo And Chairman | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-25 | 12,500 | $19.71 | 91,897 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-25 | 3,467 | $122.58 | 88,430 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-25 | 8,517 | $123.31 | 79,913 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-25 | 253 | $124.19 | 79,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-25 | 263 | $125.17 | 79,397 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-11-25 | 12,500 | $0.00 | 12,500 | $19.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,000 | 2026-01-21 | No | 4 | M | Direct |
Footnotes
- The Form 4 filed on 11/26/2024 erroneously reported 75,000 options exercised in column 4 of Table I and columns 5 and 7 of Table II. The purpose of this amendment is to correct those amounts and the related totals in column 5 of Table I.
- This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.92 to $122.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.92 to $123.91, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.95 to $124.22, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.25, inclusive.
- All options are fully vested.
Billionaire Hedge Funds
